Mahoney, Kathleen M.
Freeman, Gordon J. http://orcid.org/0000-0002-7210-5616
Article History
First Online: 10 December 2019
Competing interests
: G.J.F. has served on advisory boards for Roche, Bristol-Myers-Squibb, Xios, Origimed, Triursus, iTeos and NextPoint; has equity in NextPoint, Triursus and Xios; and has the following patents on the PD-L1/PD-L2/PD-1 pathway and tumor immunotherapy: United States patents US 6808710, US 6936704, US 7038013, US 7101550, US 7105328, US 7432059, US 7635757, US 7638492, US 7700301, US 7709214, US 7722868, US 8552154, US 8652465, US 9102727, US 9457080, US 9598491, US 9683048, US 9815898, US 9845356, US 9988452, US 10011656, US 10202454, US 10370446 and US 10370448.